• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼移植物抗宿主病的研究进展:发病机制、临床表现与治疗。

A Review of Ocular Graft-versus-Host Disease: Pathophysiology, Clinical Presentation and Management.

机构信息

Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA.

Department of Ophthalmology, University of Texas McGovern Medical School, Houston, Texas, USA.

出版信息

Ocul Immunol Inflamm. 2021 Aug 18;29(6):1190-1199. doi: 10.1080/09273948.2021.1939390. Epub 2021 Jul 6.

DOI:10.1080/09273948.2021.1939390
PMID:34228599
Abstract

Graft-versus-host disease is a common complication following allogeneic hematopoetic stem cell transplantation that can affect multiple organ systems, including the eyes. Ocular GVHD (oGVHD) is characterized by a T cell-mediated immune response that leads to immune cell infiltration and inflammation of ocular structures, including the lacrimal glands, eyelids, cornea and conjunctiva. oGVHD has a significant negative impact on visual function and quality of life and successful management requires a multi-disciplinary approach with frequent monitoring. Here, we review the pathophysiology and clinical presentation of oGVHD, along with current therapeutic strategies based on our clinical experience and the reported literature.

摘要

移植物抗宿主病是异基因造血干细胞移植后的一种常见并发症,可影响多个器官系统,包括眼睛。眼部移植物抗宿主病(oGVHD)的特征是 T 细胞介导的免疫反应,导致免疫细胞浸润和眼部结构的炎症,包括泪腺、眼睑、角膜和结膜。oGVHD 对视觉功能和生活质量有显著的负面影响,成功的管理需要多学科的方法和频繁的监测。在这里,我们根据我们的临床经验和报告的文献,回顾了 oGVHD 的病理生理学和临床表现,以及当前的治疗策略。

相似文献

1
A Review of Ocular Graft-versus-Host Disease: Pathophysiology, Clinical Presentation and Management.眼移植物抗宿主病的研究进展:发病机制、临床表现与治疗。
Ocul Immunol Inflamm. 2021 Aug 18;29(6):1190-1199. doi: 10.1080/09273948.2021.1939390. Epub 2021 Jul 6.
2
How does ocular graft-versus-host disease fit under the dry eye umbrella? A review.眼部移植物抗宿主病如何归入干眼范畴?一篇综述。
Clin Exp Ophthalmol. 2024 Mar;52(2):167-185. doi: 10.1111/ceo.14347. Epub 2024 Jan 10.
3
Ocular surface system alterations in ocular graft-versus-host disease: all the pieces of the complex puzzle.眼部移植物抗宿主病中的眼表系统改变:复杂谜题的所有碎片。
Graefes Arch Clin Exp Ophthalmol. 2019 Jul;257(7):1341-1351. doi: 10.1007/s00417-019-04301-6. Epub 2019 Apr 3.
4
Update on ocular graft-versus-host disease.眼移植物抗宿主病的最新进展。
Indian J Ophthalmol. 2021 May;69(5):1038-1050. doi: 10.4103/ijo.IJO_2016_20.
5
Understanding Ocular Graft-versus-Host Disease to Facilitate an Integrated Multidisciplinary Approach.了解眼部移植物抗宿主病,以促进综合多学科方法。
Transplant Cell Ther. 2024 Sep;30(9S):S570-S584. doi: 10.1016/j.jtct.2024.06.031. Epub 2024 Jul 8.
6
Immunopathological mechanisms and clinical manifestations of ocular graft-versus-host disease following hematopoietic stem cell transplantation.造血干细胞移植后眼移植物抗宿主病的免疫病理机制和临床表现。
Bone Marrow Transplant. 2024 Aug;59(8):1049-1056. doi: 10.1038/s41409-024-02321-3. Epub 2024 May 31.
7
The ocular graft-versus-host disease: the path from current knowledge to future managements.眼移植物抗宿主病:从现有知识到未来管理的途径。
Eye (Lond). 2023 Jul;37(10):1982-1992. doi: 10.1038/s41433-022-02288-9. Epub 2022 Nov 4.
8
Ocular surface evaluation in allogenic hematopoietic stem cell transplantation patients.异基因造血干细胞移植患者的眼表评估
Eur J Ophthalmol. 2014 Sep-Oct;24(5):655-66. doi: 10.5301/ejo.5000451. Epub 2014 Mar 7.
9
[Clinical Signs of Ocular Graft-versus-Host Disease].[眼部移植物抗宿主病的临床体征]
Klin Monbl Augenheilkd. 2015 May;232(5):647-51. doi: 10.1055/s-0035-1545836. Epub 2015 May 19.
10
Ocular graft-versus-host disease (oGVHD): From A to Z.眼移植物抗宿主病(oGVHD):从 A 到 Z。
Surv Ophthalmol. 2023 Jul-Aug;68(4):697-712. doi: 10.1016/j.survophthal.2023.02.006. Epub 2023 Mar 2.

引用本文的文献

1
Novel Tear Biomarkers in Ocular Graft Versus Host Disease Associated with Th1/Th2 Immune Responses: A Case Series and Literature Review.与Th1/Th2免疫反应相关的眼部移植物抗宿主病中的新型泪液生物标志物:病例系列及文献综述
Int J Mol Sci. 2025 May 1;26(9):4311. doi: 10.3390/ijms26094311.
2
Human cornea-derived mesenchymal stromal cells inhibit T cells through indoleamine 2,3 dioxygenase.人角膜间充质基质细胞通过吲哚胺2,3-双加氧酶抑制T细胞。
Cytotherapy. 2025 May;27(5):597-608. doi: 10.1016/j.jcyt.2025.01.009. Epub 2025 Jan 20.
3
Systemic Treatment with the Janus Kinase Inhibitor Baricitinib in Ocular Chronic Graft-versus-Host Disease.
使用JAK激酶抑制剂巴瑞替尼进行全身治疗在眼部慢性移植物抗宿主病中的应用
Ophthalmol Sci. 2024 Sep 30;5(1):100627. doi: 10.1016/j.xops.2024.100627. eCollection 2025 Jan-Feb.
4
Safety and efficacy of human amniotic epithelial stem cell eye drops in ocular chronic graft--host disease.人羊膜上皮干细胞滴眼液治疗眼部慢性移植物抗宿主病的安全性和有效性
Haematologica. 2025 Feb 1;110(2):470-474. doi: 10.3324/haematol.2023.284571.
5
Frequency of Topical Immunomodulatory and Immunosuppressive Therapies for Ocular Chronic Graft-versus-Host Disease.眼部慢性移植物抗宿主病局部免疫调节和免疫抑制疗法的使用频率
J Clin Med. 2024 Aug 12;13(16):4728. doi: 10.3390/jcm13164728.
6
Sustained descemetocele management with Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) treatment.采用眼表生态系统假体置换术(PROSE)治疗持续性后弹力层膨出
Am J Ophthalmol Case Rep. 2024 Jun 25;36:102092. doi: 10.1016/j.ajoc.2024.102092. eCollection 2024 Dec.
7
CAR-Treg cell therapies and their future potential in treating ocular autoimmune conditions.嵌合抗原受体调节性T细胞(CAR-Treg)疗法及其在治疗眼部自身免疫性疾病方面的未来潜力。
Front Ophthalmol (Lausanne). 2023 Apr 18;3:1184937. doi: 10.3389/fopht.2023.1184937. eCollection 2023.
8
Different concentrations of hyaluronic acid eye drops for dry eye syndrome: a systematic review and Meta-analysis.不同浓度透明质酸钠滴眼液治疗干眼症的系统评价与Meta分析
Int J Ophthalmol. 2024 Jun 18;17(6):1110-1119. doi: 10.18240/ijo.2024.06.17. eCollection 2024.
9
Immunopathological mechanisms and clinical manifestations of ocular graft-versus-host disease following hematopoietic stem cell transplantation.造血干细胞移植后眼移植物抗宿主病的免疫病理机制和临床表现。
Bone Marrow Transplant. 2024 Aug;59(8):1049-1056. doi: 10.1038/s41409-024-02321-3. Epub 2024 May 31.
10
"Window of Opportunity" in Ocular Graft-Versus-Host Disease Treatment: Results of a Longitudinal Study and Case Reports.眼部移植物抗宿主病治疗中的“机会窗”:一项纵向研究及病例报告结果
Eye Contact Lens. 2024 May 1;50(5):222-232. doi: 10.1097/ICL.0000000000001081. Epub 2024 Mar 13.